Autor(en) Titel Quelle Links
Wabitsch M, Kunze D (federführend für die AGA) Konsensbasierte (S2) Leitlinie zur Diagnostik, Therapie und Prävention von Übergewicht und Adipositas im Kindes- und Jugendalter. Version 15.10.2015,    
Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K, Buhlmann P, Niggli F, Schafer B Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 2004, 64: 5539    
Wachtel M, Runge T, Leuschner I, Stegmaier S, Koscielniak E, Treuner J, Odermatt B, Behnke S, Niggli FK, Schäfer BW Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. Journal of clinical oncology 2006, 24: 816    
Wachowiak J, Sykora KW, Cornish J, Chybicka A, Kowalczyk JR, Gorczyńska E, Choma M, Grund G, Peters C Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party. Bone Marrow Transplant 2011, Epub ahead of print    
Wagner HJ, Schlager F, Claviez A, Bucsky P Detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction. Eur J Cancer 2001, 37: 1853    
Wagner S, Sörensen N, Kortmann RD, Gnekow A, Kühl J, Wolff JEA HIT-GBM data bank: Overall survival in relation to extent to resection; SIOP XXXIV Meeting, Porto, Portugal. Medical and Pediatric Oncology 2002, 39 : 242    
Wagner S Therapie von hochgradig malignen Gliomen im Kindes- und Jugendalter. WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2003, 1: 13    
Wagner-Bohn A, Henze G, von Stackelberg A, Boos J Phase II study of gemcitabine in children with relapsed leukemia. Pediatric blood & cancer 2006, 46: 262    
Wagner S, Benesch M, Berthold F, Gnekow AK, Rutkowski S, Sträter R, Warmuth-Metz M, Kortmann RD, Pietsch T, Wolff JE Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas. Br J Cancer 95: 991    
Wagner LM, McAllister N, Goldsby RE, Rausen AR, McNall-Knapp RY, McCarville MB, Albritton K Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatric blood & cancer 2007, 48: 132    
Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007, 109: 2256    
Wahn V, Aberer W, Eberl W, Faßhauer M, Kühne T, Kurnik K, Magerl M, Meyer-Olson D, Martinez-Saguer I, Späth P, Staubach-Renz P, Kreuz W Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies. European journal of pediatrics 2012, 171: 1339    
Wahn V, Aberer W, Aygören-Pürsün E, Bork K, Eberl W, Faßhauer M, Krüger R, Magerl M, Martinez-Saguer I, Späth P, Staubach-Renz P, Weber-Chrysochoou C Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries. Pediatric allergy and immunology 2020, Epup ahead of print    
Wang JL, Huang LT, Wu KH, Lin HW, Ho MY, Liu HE Associations of reactive thrombocytosis with clinical characteristics in pediatric diseases. Pediatrics and neonatology 2011t; 52: 261    
Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991, 324: 1385    
Wargalla-Plate U, Hero B, Berthold F Neuroblastoma. Schweiz Rundsch Med Prax 1995, 84: 1152    
Warmann S, Fuchs J, Wilkens L, Gratz K, von Schweinitz D, Mildenberger H Successful therapy of subcutaneously growing human hepatoblastoma xenografts with topotecan. Med Pediatr Oncol 2001, 37: 449    
Warmuth-Metz M, Kühl J Neuroradiological differential diagnosis in medulloblastomas and ependymomas. Klin Pädiatr 2002, 214: 162    
Warmuth-Metz M, Kühl J, Rutkowski S, Krauss J, Solymosi L Differential infratentorial brain tumor diagnosis in children. Radiologe 2003, 43: 977    
Warmuth-Metz M, Kühl J, Krauss J, Solymosi L Subdural enhancement on postoperative spinal MRI after resection of posterior cranial fossa tumours. Neuroradiology 2004, 46: 219    
Warmuth-Metz M, Gnekow AK, Muller H, Solymosi L Differential diagnosis of suprasellar tumors in children. Klinische Padiatrie 2004, 216: 323    
Warmuth-Metz M, Blashofer S, von Bueren AO, von Hoff K, Bison B, Pohl F, Kortmann RD, Pietsch T, Rutkowski S Recurrence in childhood medulloblastoma. J Neurooncol 2010, Epub ahead of print]    
Warmann SW, Nourkami N, Frühwald M, Leuschner I, Schenk JP, Fuchs J, Graf N Primary Lung Metastases in Pediatric Malignant Non-Wilms Renal Tumors: Data from SIOP 93-01/GPOH and SIOP 2001/GPOH. Klinische Padiatrie 2012, 224: 148    
Warmuth-Metz M, Bison B, Gerber NU, Pietsch T, Hasselblatt M, Frühwald MC Bone Involvement in Atypical Teratoid/Rhabdoid Tumors of the CNS. AJNR. American journal of neuroradiology 2013, Epub ahead of print    
Ware RE Hydroxycarbamide: Clinical aspects. Comptes rendus biologies 2013, 336: 177    
Wasilewski-Masker K, Seidel KD, Leisenring W, Mertens AC, Shnorhavorian M, Ritenour CW, Stovall M, Green DM, Sklar CA, Armstrong GT, Robison LL, Meacham LR Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study. Journal of cancer survivorship : research and practice 2014, 8: 437    
Weber R, Pietsch T, von Schweinitz D, Lichter P Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000, 157: 571    
Weber A, Taube S, Starke S, Bergmann E, Christiansen NM, Christiansen H Detection of human tumor cells by amplicon fusion site polymerase chain reaction (AFS-PCR). J Clin Invest 2011, 121: 545    
Weber ML, Schneider DT, Offenmüller S, Kaatsch P, Einsiedel HG, Benesch M, Claviez A, Ebinger M, Kramm C, Kratz C, Lawlor J, Leuschner I, Merkel S, Metzler M, Nustede R, Petsch S, Seeger KH, Schlegel PG, Suttorp M, Zolk O, Brecht IB Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes. Pediatric blood & cancer 2016, 63: 611    
Wegert J, Vokuhl C, Ziegler B, Ernestus K, Leuschner I, Furtwängler R, Graf N, Gessler M TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia. The journal of pathology. Clinical research 2017, 3: 234    
Weh H, Kuse R, Hoffmann R, Seeger D, Suciu S, Kabisch H, Ritter J, Hossfeld D Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML). Blut 1988, 56: 19    
Weh H, Hoffmann R, Suciu S, Ritter J, Kuse K, Hossfeld D Prognostic significance of chromosome analysis in de novo acute myeloid leucemia. Haematology and Blood Transfusion 1990, 33: 150    
Weirich A, Ludwig R Das Nephroblastom - Diagnose, Therapie und Prognose. Nierentumoren 1997    
Weirich A, Leuschner I, Harms D, Vujanic G, Troger J, Abel U, Graf N, Schmidt D, Ludwig R, Voute P Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol 2001, 12: 311    
Weidner R, Pollmann S, Muller H, von Cramon D Top-down controlled visual dimension weighting. Cereb Cortex 2002, 12: 318    
Weirich A, Ludwig R, Graf N, Abel U, Leuschner I, Vujanic G, Mehls O, Boos J, Beck J, Royer-Pokora B, Voute P Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol 2004, 15: 808    
Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, Whiteford CC, Bilke S, Krasnoselsky AL, Cenacchi N, Catchpoole D, Berthold F, Schwab M, Khan J Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer research 2004, 64: 6883    
Weihkopf T, Blettner M, Dantonello T, Jung I, Klingebiel T, Koscielniak E, Lückel M, Spix C, Kaatsch P Incidence and time trends of soft tissue sarcomas in German children 1985-2004 - a report from the population-based German Childhood Cancer Registry. European journal of cancer 2008, 44: 432    
Weimar, C et al.tri Zerebrale Sinus - und Venenthrombose. Leitlinien für Diagnostik und Therapie in der Neurologie (Hrsg.: Diener HC, Weimar C) 2012    
Welte K, Reiter A, Mempel K, Pfetsch M, Schwab G, Schrappe M, Riehm H A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group. Blood 1996, 87: 3143    
Wellmann S Guschmann Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF. Leukemia 2004    
Wellmann S, Moderegger E, Zelmer A, Bettkober M, von Stackelberg A, Henze G, Seeger K FLT3 mutations in childhood acute lymphoblastic leukemia at first relapse. Leukemia 2005, 19: 467    
Welte K, Zeidler C, Dale DC Severe congenital neutropenia. Seminars in hematology 2006, 43: 189    
Wells EM, Walsh KS, Khademian ZP, Keating RF, Packer RJ The cerebellar mutism syndrome and its relation to cerebellar cognitive function and the cerebellar cognitive affective disorder. Developmental disabilities research reviews 2008, 14: 221    
Wenninger K, Helmes A, Bengel J, Lauten M, Völkel S, Niemeyer CM Coping in long-term survivors of childhood cancer: relations to psychological distress. Psycho-oncology 2013, 22: 854    
Werner M, Fuchs N, Salzer-Kuntschik M, Winkler K, Delling G Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up. Pathologe 1996, 17: 35    
Werner M, Heintz A, Delling G DNA cytometry of solitary and aneurysmal bone cysts and low malignancy and high malignancy central osteosarcomas. Current significance within the scope of morphologic diagnosis of intraosseous cystic and osteoblastic lesions. Pathologe 1996, 17: 44    
Wermes C, Rietze M, Sykora KW, Ganser A Integrationsprojekt als Weg in die Zukunft Erfolgreicher Einstieg in das Berufsleben für Jugendliche mit Hämophilie. Hämostaseologie, Supplement 2010, 30 1: 60-61    
Westermeier T, Michaelis J Applicability of the Poisson distribution to model the data of the German Children's Cancer Registry. Radiat Environ Biophys 1995, 34: 7    
Wessalowski R, Blohm M, Calaminus G, Engert J, Harms D, Krause I, Kruck H, Grüttner HP, Pape H, Göbel U Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort. Klinische Padiatrie 1997, 209: 250    
Wessalowski R, Kruck H, Pape H, Kahn T, Willers R, Göbel U Hyperthermia for the treatment of patients with malignant germ cell tumors. Cancer 1998, 82: 793    
Westermeier T, Kaatsch P, Schoetzau A, Michaelis J Multiple primary neoplasms in childhood. Eur J Cancer 1998, 34: 687    
Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome biology 2008, 9:R150    
Wessel T, Balcerek M, Reinmuth S, Hohmann C, Keil T, Henze G, Borgmann-Staudt A Age at menarche in childhood cancer survivors: results of a nationwide survey in Germany. Hormone research in paediatrics 2012, 77: 108    
Wessel T, Balcerek M, Reinmuth S, Hohmann C, Keil T, Henze G, Borgmann-Staudt A Age at menarche in childhood cancer survivors: results of a nationwide survey in Germany. Hormone research in paediatrics 2012, 77: 108    
Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. The lancet oncology 2013, 14: 843    
Weyand AC, Pipe SW New therapies for hemophilia. Blood 2019 Jan 31; 133: 389    
Whelan J, McTiernan A, Weston C, Douglas C, Grimer R, Cassoni A, Paulussen M, Jürgens H, Craft A, Lewis, I Consequences of different approaches to local treatment of Ewing's sarcoma within an international randomised controlled trial: Analysis of EICESS-92. Journal of Clinical Oncology 2006, 24; 528S    
Whelan KF, Stratton K, Kawashima T, Waterbor JW, Castleberry RP, Stovall M, Sklar CA, Packer RJ, Mitby P, Aitken CL, Blatt J, Robison LL, Mertens AC Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study. Pediatric blood & cancer 2010, 54: 103    
Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M, EURAMOS collaborators EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015, 26: 407    
Whelan J, Hackshaw A, McTiernan A, Grimer R, Spooner D, Bate J, Ranft A, Paulussen M, Jürgens H, Craft A, Lewis I Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92. Clinical sarcoma research 2018, 8: 6    
Whelan J, Le Deley MC, Dirksen U, Le Teuff G, Brennan B, Gaspar N, Hawkins DS, Amler S, Bauer S, Bielack S, Blay JY, Burdach S, Castex MP, Dilloo D, Eggert A, Gelderblom H, Gentet JC, Hartmann W, Hassenpflug WA, Hjorth L, Jimenez M, Klingebiel T, Kontny U, Kruseova J, Ladenstein R, Laurence V, Lervat C, Marec-Berard P, Marreaud S, Michon J, Morland B, Paulussen M, Ranft A, Reichardt P, van den Berg H, Wheatley K, Judson I, Lewis I, Craft A, Jürgens H, Oberlin O, Euro-EWING99 and EWING-2008 Investigators High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E. W.I. N.G. 99 and Ewing-2008. J Clin Oncol 2018    
White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, Factor VIII and Factor IX Subcommittee Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001, 85: 560    
Whitehead VM Acquired and inherited disorders of cobalamin and folate in children. British journal of haematology 2006, 134: 125    
World Health Organization Classification of Tumours Pathology and genetics: tumours of haematopoietic and lymphoid tussues. IARC Press, Lyon 2001    
World Health Organisation Iron deficiency anemia. Assessment, prevention and control. 2001    
WHO Press International Classification of Functioning, Disability and Health: Children and Youth Version. Geneva. WHO Press 2007, ISBN 978 92 4 154732 1    
World Health Organisation Worldwide prevalence of anaemia 1993–2005. 2008    
World Health Organization 2008-2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. WHO 2009    
Wickramasinghe SN Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood reviews 1998, 12: 178    
Wickmann L, Lüders H, Dörffel W 18-FDG-PET-Befunde bei Kindern und Jugendlichen mit Morbus Hodgkin. Klin Pädiatr 2003, 215: 146    
Widemann BC, Balis FM, Murphy RF, Sorensen JM, Montello MJ, O'Brien M, Adamson PC Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. J Clin Oncol 1997, 15: 2125    
Widemann B, Balis F, Kempf-Bielack B, Bielack S, Pratt C, Ferrari S, Bacci G, Craft A, Adamson P High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer 2004, 100: 2222    
Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst 2004, 96: 1557    
Widemann BC, Balis FM, Kim A, Boron M, Jayaprakash N, Shalabi A, O'Brien M, Eby M, Cole DE, Murphy RF, Fox E, Ivy P, Adamson PC Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome. J Clin Oncol 2010, 28: 3979    
Wieland R, Havers W Retinoblastome. In: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006, 823    
Wieland R, Havers W Retinoblastome, in: Gadner H, Gaedicke G, Niemeyer CH, Ritter J: Pädiatrische Hämatologie und Onkologie. Springer Medizin Verlag 2006, 823    
Wiese M, Walther N, Diederichs C, Schill F, Monecke S, Salinas G, Sturm D, Pfister SM, Dressel R, Johnsen SA, Kramm CM The ß-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Oncotarget 2017 Apr 18; 8: 27300    
Wiederer L, Bertsch A, Eber S Seltene Anämien im Kindesalter. Päd Prax 2020, 94: 85    
Willig TN, Niemeyer CM, Leblanc T, Tiemann C, Robert A, Budde J, Lambiliotte A, Kohne E, Souillet G, Eber S, Stephan JL, Girot R, Bordigoni P, Cornu G, Blanche S, Guillard JM, Mohandas N, Tchernia G Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatric research 1999, 46: 553    
Willemse M, Seriu T, Hettinger K, D'Aniello E, Hop W, Panzer-Grumayer E, Biondi A, Schrappe M, Kamps W, Masera G, Gadner H, Riehm H, Bartram C, van Dongen J Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 2002, 99: 4386    
Wilda M, Bruch J, Harder L, Rawer D, Reiter A, Borkhardt A, Woessmann W Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children. Leukemia 2004, 18: 584    
Willich N, Ernst I, Pape H, Rübe C, Timmermann B, Asadpour B, Kortmann RD, Bölling T Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach. Strahlentherapie und Onkologie 2009, 185 Suppl 2: 3    
Willer A, Gerss J, König T, Franke D, Kühnel HJ, Henze G, von Stackelberg A, Möricke A, Schrappe M, Boos J, Lanvers-Kaminsky C Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials. Blood 2011, 118: 5774    
Wilne S, Collier J, Kennedy C, Jenkins A, Grout J, Mackie S, Koller K, Grundy R, Walker D Progression from first symptom to diagnosis in childhood brain tumours. European journal of pediatrics 2012, 171: 87    
Wilhelm M, Dirksen U, Bielack SS, Whelan JS, Lewis IJ, Jürgens H, Ferrari S, Sundby Hall K, Cleton-Jansen AM, Stark D ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas. Annals of oncology 2014, 25: 1500    
Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitra-Roussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Kriván G, Hamladji RM, Diaz-de-Heredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, Veys P, Dupont S, Or R, Güngör T, Aleinikova O, Sufliarska S, Sundin M, Rascon J, Kaare A, Nemet D, Fagioli F, Klingebiel TE, Styczynski J, Bierings M, Nagy K, Abecasis M, Afanasyev B, Ansari M, Vettenranta K, Alseraihy A, Chybicka A, Robinson S, Bertrand Y, Kupesiz A, Ghavamzadeh A, Campos A, Pichler H, Dalissier A, Labopin M, Corbacioglu S, Balduzzi A, Galimard JE, Bader P, EBMT Paediatric Diseases Working Party Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. Bone marrow transplantation 2020, Epup ahead of print    
Willasch AM, Peters C, Sedláček P, Dalle JH, Kitra-Roussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Kriván G, Hamladji RM, Diaz-de-Heredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, Veys P, Dupont S, Or R, Güngör T, Aleinikova O, Sufliarska S, Sundin M, Rascon J, Kaare A, Nemet D, Fagioli F, Klingebiel TE, Styczynski J, Bierings M, Nagy K, Abecasis M, Afanasyev B, Ansari M, Vettenranta K, Alseraihy A, Chybicka A, Robinson S, Bertrand Y, Kupesiz A, Ghavamzadeh A, Campos A, Pichler H, Dalissier A, Labopin M, Corbacioglu S, Balduzzi A, Galimard JE, Bader P, EBMT Paediatric Diseases Working Party Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. Bone marrow transplantation 2020, Epup ahead of print    
Wimmer K, Zhu X, Lamb B, Kuick R, Ambros P, Kovar H, Thoraval D, Elkahloun A, Meltzer P, Hanash S Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Med Pediatr Oncol 2001, 36: 75    
Wimmer R, Eckart M, Meyer-Puttlitz B, Fonatsch C, Pietsch T Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas. J Neuropathol Exp Neurol 2002, 61: 896    
Winkler K, Bieling P, Bielack S Chemotherapy of osteosarcoma. Z Orthop Ihre Grenzgeb 1992, 130: 285    
Winkler K, Bielack S, Delling G, Jürgens H, Kotz R, Salzer-Kuntschik M Treatment of osteosarcoma. Cancer Treat Res 1993, 62: 269    
Winkler K Maligne Tumoren des Knochens - Osteosarkoms23. Hämatologie-Onkologie 1995    
Winkler K Osteosarkom24. Therapiekonzepte Onkologie 1995    
Wirth S Handlungsempfehlung nach der Leitlinie Eisenmangelanämie. Monatsschr Kinderheilkd 2012, 160: 275–276    
Wisoff JH, Sanford RA, Heier LA, Sposto R, Burger PC, Yates AJ, Holmes EJ, Kun LE Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group. Neurosurgery 2011, 68: 1548-54; discussion 1554    
Witt V Blutungen und Thromboembolien. Pädiatrische Onkologie und Hämatologie, Hrsg: Gadner, H, Gaedicke G 2006    
Witt V, Pichler H, Fritsch G, Peters C Multiple small versus few large amount aspirations for bone marrow harvesting in autologous and allogeneic bone marrow transplantation. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2016, 55: 221    
Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, Ludwig W, Klingebiel T, Graf N, Gruhn B, Jürgens H, Niggli F, Parwaresch R, Gadner H, Riehm H, Schrappe M, Reiter A The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms - a report of the BFM group study NHL-BFM95. Blood 2004    
Wolfl M, Jungbluth AA, Garrido F, Cabrera T, Meyen-Southard S, Spitz R, Ernestus K, Berthold F Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma. Cancer immunology, immunotherapy : CII 2005, 54: 400    
Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, Ludwig WD, Klingebiel T, Graf N, Gruhn B, Jürgens H, Niggli F, Parwaresch R, Gadner H, Riehm H, Schrappe M, Reiter A, BFM Group The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005, 105: 948    
Woessmann W, Peters C, Lenhard M, Burkhardt B, Sykora KW, Dilloo D, Kremens B, Lang P, Fuhrer M, Kuhne T, Parwaresch R, Ebell W, Reiter A Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report. Br J Haematol 2006, 133: 176    
Woessmann W, Zimmermann M, Lenhard M, Burkhardt B, Rossig C, Kremens B, Lang P, Attarbaschi A, Mann G, Oschlies I, Klapper W, Reiter A Relapsed or Refractory Anaplastic Large-Cell Lymphoma in Children and Adolescents After Berlin-Frankfurt-Muenster (BFM)-Type First-Line Therapy: A BFM-Group Study. J Clin Oncol 2011, [Epub ahead of print]    
Wolfrom C, Hartmann R, Fengler R, Brühmuller S, Ingwersen A, Henze G Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol 1993, 11: 827    
Wolfrom C, Hartmann R, Brühmuller S, Fengler R, Reiter A, Ritter J, Henze G Similar outcome in boys with isolated and combined testicular acute lymphoblastic leukemia relapse after stratified BFM salvage therapy. Haematol Blood Transfus 1996, 38: 647    
Wolf J, Schellong G, Diehl V Breast cancer following treatment of Hodgkin's disease--more reasons for less radiotherapy? Eur J Cancer 1997, 33: 2293    
Wolff J, Hauch H, Kühl J, Egeler R, Jürgens H Dexamethasone increases hepatotoxicity of MTX in children with brain tumors. Anticancer Res 1998, 18: 2895    
Wolff J, Kühl J, Bamberg M, Krauseneck P Hirntumoren im Kindesalter. Kompendium internistische Onkologie 1998,Band 2    
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000, 342: 326    
Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N, Kühl J Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 2002, 94: 264    
Wolff JEA Hochgradig maligne Gliome und Ponsgliome im Kindes- und Jugendalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2006    
Wolff JE, Kramm C, Kortmann RD, Pietsch T, Rutkowski S, Jorch N, Gnekow A, Driever PH Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma. J Neurooncol 2008, 90: 309    
Wolff JE, Berrak S, Koontz Webb SE, Zhang M Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients. J Neurooncol 2008, 88: 57    
Wolff JE, Classen CF, Wagner S, Kortmann RD, Palla SL, Pietsch T, Kühl J, Gnekow A, Kramm CM Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. J Neurooncol 2008, 87: 155    
Wolff JE, Classen CF, Wagner S, Kortmann RD, Palla SL, Pietsch T, Kühl J, Gnekow A, Kramm CM Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. Journal of neuro-oncology 2008, 87: 155    
Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer 2010, 116: 705    
Wolff JE, Mohiuddin K, Jorch N, Graf N, Wagner S, Vats T, Gnekow A Measuring performance status in pediatric patients with brain tumors--experience of the HIT-GBM-C protocol. Pediatr Blood Cancer 2010, 55: 520    
Wolff B, Ng A, Roth D, Parthey K, Warmuth-Metz M, Eyrich M, Kordes U, Kortmann R, Pietsch T, Kramm C, Wolff JE Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database. Journal of neuro-oncology 2011,Epub ahead of print    
Wolff JE, Rytting ME, Vats TS, Zage PE, Ater JL, Woo S, Kuttesch J, Ketonen L, Mahajan A Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience. Journal of neuro-oncology 2011,Epub ahead of print    
von Wolff M , Dittrich R Übersicht - Kinderwunsch bei Krebspatientinnen - Beratungs- und Therapiestandards. TumorDiagn u Ther 2013, 34: 320    
Wolffenbuttel BHR, Wouters HJCM, Heiner-Fokkema MR, van der Klauw MM The Many Faces of Cobalamin (Vitamin B12) Deficiency. Mayo Clinic proceedings. Innovations, quality & outcomes 2019, 3: 200    
Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr, Li FP Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA : the journal of the American Medical Association 1997, 278: 1262    
Wood I School. In: Goldmann A, Hain R, Liben S (eds) Oxford textbook of palliative care in children 2006, pp129    
Worch J, Ranft A, DuBois SG, Paulussen M, Jürgens H, Dirksen U Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma. Pediatric blood & cancer 2018, 65:e27251    
Wossmann W, Schrappe M, Meyer U, Zimmermann M, Reiter A Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Annals Hematology 2003, 82: 160    
Wrede B, Liu P, Wolff JE Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors. J Neurooncol 2007, 85: 345    
Wrede B, Hasselblatt M, Peters O, Thall PF, Kutluk T, Moghrabi A, Mahajan A, Rutkowski S, Diez B, Wang X, Pietsch T, Kortmann RD, Paulus W, Jeibmann A, Wolff JE Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study. J Neurooncol 2009, 95: 383    
Wrobel G, Mauguen A, Rosolen A, Reiter A, Williams D, Horibe K, Brugières L, Le Deley MC, on behalf of European Inter-Group for Childhood, Non-Hodgkin Lymphoma (EICNHL) Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: Report of the ALCL99 randomised trial. Pediatr Blood Cancer 2011, Epub ahead of print    
Wu S, Korte A, Gessner R, Henze G, Seeger K Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence. Cancer 2003, 98: 625    
Wuchter C, Harbott J, Schoch C, Schnittger S, Borkhardt A, Karawajew L, Ratei R, Ruppert V, Haferlach T, Creutzig U, Dorken B, Ludwig W Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7. 1 Leukemia 2000, 14: 1232    
Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R, Dorken B, Ludwig W Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia. Br J Haematol 2000, 110: 154    
Wuchter C, Leonid K, Ruppert V, Schrappe M, Buchner T, Schoch C, Haferlach T, Harbott J, Ratei R, Dorken B, Ludwig W Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. haematologica 2000, 85: 711    
Wuchter C, Ratei R, Spahn G, Schoch C, Harbott J, Schnittger S, Haferlach T, Creutzig U, Sperling C, Karawajew L, Ludwig W Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping. haematologica 2001, 86: 154    
Wuchter C, Ruppert V, Schrappe M, Dorken B, Ludwig W, Karawajew L In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood 2002, 99: 4109    
Wuerthwein G, Lanvers-Kaminsky C, Gerss J, Moericke A, Zimmermann M, Stary J, Smisek P, Attarbaschi A, Nath C, Zucchetti M, Rizzari C, Schrappe M, Boos J Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study. Therapeutic drug monitoring 2020, 42: 435    
Wutz D, Shayan P, Schmahl G, Mild G, Feil B, Roll S, Kontny H, Niemeyer C Gene expression of the hematopoietic cell phosphatase in juvenile myelomonocytic leukemia. Leuk Lymphoma 1999, 35: 491    
Wykes C, Arasaretnam A, O'Driscoll S, Farnham L, Moniz C, Rees DC Vitamin D deficiency and its correction in children with sickle cell anaemia. Annals of hematology 2014,    
Wölfl M, Schalk S, Hellmich M, Huster K, Busch D, Berthold F Quantitation of MHC tetramer-positive cells from whole blood. Cytometry 2004, 57A: 120    
Würthwein G, Krümpelmann S, Tillmann B, Real E, Schulze-Westhoff P, Jürgens H, Boos J Population pharmacokinetic approach to compare oral and i. v. administration of etoposide. Anticancer Drugs 1999, 10: 807    
139 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.